Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Waldenstrom Macroglobulinemia × cediranib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Fallopian Tube Neoplasms 6 Ovarian Neoplasms 5 Colorectal Neoplasms 5 Prostatic Neoplasms 4 Neoplasms 4 Glioblastoma 4 Carcinoma, Renal Cell 3 Triple Negative Breast Neoplasms 2 Solitary Fibrous Tumor, Pleural 2 Sarcoma, Alveolar Soft Part 2 Sarcoma 2 Mesothelioma, Malignant 2 Lung Neoplasms 2 Gliosarcoma 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Uveal Melanoma 1 Thyroid cancer, Hurthle cell 1 Thyroid Cancer, Papillary 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neoplasm Metastasis 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1

Interventions

Rituximab 44 fludarabine phosphate 24 Cyclophosphamide 22 Whole-Body Irradiation 21 Peripheral Blood Stem Cell Transplantation 19 Mycophenolic Acid 18 Cyclosporine 14 Tacrolimus 13 Dexamethasone 13 ibrutinib 11 Bortezomib 11 Calcium Dobesilate 10 Busulfan 10 Antilymphocyte Serum 9 Sirolimus 8 Etoposide 8 Methotrexate 7 Lenalidomide 7 Cyclosporins 7 Melphalan 6 Everolimus 6 idelalisib 5 Filgrastim 5 thymoglobulin 4 carfilzomib 4 Indium 4 In Situ Hybridization, Fluorescence 4 Granulocyte Colony-Stimulating Factor 4 Flow Cytometry 4 pembrolizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡